NCT06239844 · University of Colorado, Denver
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
(Nav-TEAM)
What this study is about
The Nav-Team study reviews how well the asthma navigators/coordinator program can improve the lives of asthmatic children, and their caregivers, by providing additional assistance and education. Aim 1 of the study will partner with immigrant serving community organizations to hold meetings that will help tailor the programs.
View original scientific description
The Nav-Team study reviews how well the asthma navigators/coordinator program can improve the lives of asthmatic children, and their caregivers, by providing additional assistance and education. Aim 1 of the study will partner with immigrant serving community organizations to hold meetings that will help tailor the programs. Aim 2 of the study looks at data to help see if the program is working to help children and their caregivers. Aim 2a looks at difference in emergency department use between families that did not use the Nav-Team program and those that did. Aim 2b reviews how well the Nav-Team program did with reaching and connecting with the asthma child and caregiver community. Aim 2b, also reviews the costs of the program, how well the program did will sticking to the program goals, and how well the staff was able to keep up with providing education and help.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- eria for Nav-TEAM Intervention Dyads include:
- Child aged 4-12 years.
- Child with persistent asthma (defined by currently prescribed controller medication).
- Parent/legal guardian who is at least 18 years old. Exclusion criteria for Nav-TEAM Intervention Dyads include:
- Child aged under 4 and over 12 years of age.
- Child with no persistent asthma (defined by currently prescribed controller medication).
- Parent/legal guardian who is under 18 years old.
- Any parent/legal guardian whose preferred spoken language is English.
- Child requires additional continuous respiratory support (e.g,. tracheostomy with home ventilation, continuous daytime oxygen).
- Child is enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs).
- Spoken non-English preferred healthcare language of parent/legal guardian.
- Child does NOT require additional continuous respiratory support (e.g., nighttime use of Continuous positive airway pressure machine for obstructive sleep apnea would be eligible).
- Child does NOT have a complex medical/genetic condition that affects swallowing or lung function (e.g. g-tube with aspiration, cystic fibrosis)
- Child is NOT enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs).
Exclusion criteria
- for Nav-TEAM Intervention Dyads include:
- Child aged under 4 and over 12 years of age.
- Child with no persistent asthma (defined by currently prescribed controller medication).
- Parent/legal guardian who is under 18 years old.
- Any parent/legal guardian whose preferred spoken language is English.
- Child requires additional continuous respiratory support (e.g,. tracheostomy with home ventilation, continuous daytime oxygen).
- Child is enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs).
- Spoken non-English preferred healthcare language of parent/legal guardian.
- Child does NOT require additional continuous respiratory support (e.g., nighttime use of Continuous positive airway pressure machine for obstructive sleep apnea would be eligible).
- Child does NOT have a complex medical/genetic condition that affects swallowing or lung function (e.g. g-tube with aspiration, cystic fibrosis)
- Child is NOT enrolled in another study health system associated asthma navigation program (e.g. school or home-visiting programs).
Where
- Aurora, Colorado
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Apr 3, 2025 · Source of record for eligibility and locations